title: Do pharmacogenomic tests provide value to policy makers?
authors.forename: Ya-Chen Tina
authors.initials: YC
authors.lastname: Shih
authors.forename: Lajos
authors.initials: L
authors.lastname: Pusztai
mesh_terms: D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D006801:Humans; D010597:Pharmacogenetics / Q000191:economics* / Q000331:legislation & jurisprudence*; D019057:Quality-Adjusted Life Years